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nitroprusside) vasodilators in 25 patients with uncomplicat-
ed isolated superficial venous incompetence (ISVI) and 26 
healthy controls.  Results: Maximum perfusion had the best 
reproducibility assessed by LDF (CV 20.5–24.3%) and LDI 
(15.8–17.6%). Both techniques were positively influenced by 
iontophoretic dose (e.g. p = 0.0001 for LDF) and the use of 
vasodilator agents (e.g. p = 0.0001 for LDF), but negatively 
influenced in the standing position and/or in the presence 
of ISVI (p = 0.0016 and 0.045, respectively, for LDF). There was 
a statistically significant positive relationship between the 
two techniques, for example ACh maximum perfusion ver-
sus LDF ACh maximum perfusion (r = 0.404, p = 0.016).  Con-
clusions: Both techniques are reproducible, in line with sim-
ilar studies undertaken in other areas of the human body, 
and provide useful information for the study of the lower-
limb microcirculation. Direct comparison between tech-
niques based on absolute numbers should be avoided and 
the technique choice should be based on individual study 
needs.  Copyright © 2011 S. Karger AG, Basel 
 Introduction 
 Adverse changes in the microvascular circulation are 
associated with many chronic diseases including venous 
disease  [1, 2] and diabetes  [3] , leading to the development 
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 Abstract 
 Purpose of Study: Non-invasive laser Doppler fluximetry 
(LDF) and laser Doppler imaging (LDI), combined with ionto-
phoresis, have been used to study the microcirculation in a 
range of clinical conditions including lower limb venous dis-
ease. A prerequisite for an accurate measurement tool is that 
it is reproducible. However, there is currently no literature 
with respect to the reproducibility of LDF and LDI combined 
with iontophoresis in the lower limb (in general) and in the 
upright position (in specific). Furthermore, the two tech-
niques have been used interchangeably by researchers and 
the association between these two different measurement 
methods has not been explored, nor have the factors that 
affect them been well described. Thus the aim of this study 
was to determine the reproducibility of LDF and LDI with 
iontophoresis in the lower limb and investigate factors that 
influence their clinical application.  Procedures: Cutaneous 
microvascular responses in the lower limb were measured in 
the supine and standing positions using LDF and LDI com-
bined with iontophoretic administration of endothelial-de-
pendent (acetylcholine, ACh) and -independent (sodium
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and application of a range of techniques to assess the mi-
crocirculation. For example, microangiopathic changes 
(in the venous microcirculation) are closely associated 
with trophic skin damage, and in turn such skin damage 
can lead to venous ulceration  [4] . Non-invasive assess-
ment of the microcirculation by laser Doppler fluximetry 
(LDF) and laser Doppler imaging (LDI) has been utilised 
as clinical surrogate marker (i.e. for systemic sclerosis 
 [5] ), to monitor postoperative tissue perfusion  [6] and 
evaluate the effect of drugs in microcirculation  [7] . Ad-
ditionally, these techniques have been widely used in re-
search in an attempt to study the effect of a range of clin-
ical conditions in endothelial function, including, 
amongst others, diabetes  [8] , atherosclerosis  [9] and low-
er limb venous disease  [10] . Although results are promis-
ing, lack of standardised procedures and poorly defined 
reproducibility have limited the number of their clinical 
applications.
 Despite the fact that these two techniques share the 
same principle  [10] there are also differences. LDF elec-
trodes are applied directly to the skin and typically mea-
sure within a small area (  1 mm 3 )  [11] , potentially lead-
ing to spatial heterogeneity and artefact movement. In 
contrast, LDI usually measures a larger skin area from a 
distance without touching the tissue, generating a colour-
coded image of the spatial distribution of tissue perfusion 
 [10] . LDI is associated with a high capital and mainte-
nance cost (currently in the order of GBP 37,500 com-
pared to the typical GBP 8,500 cost of an LDF system) 
and LDI can only provide an image of perfusion at a giv-
en point. LDF, however, provides a constant measure of 
blood flow  [12] , an important requirement when study-
ing the temporal variation of cutaneous flow.
 The technique of iontophoresis is often used as an ad-
junct to LDF and LDI. This established, non-invasive 
method enables the introduction of charged substances 
across the surface of the skin by means of a small electric 
current. This allows a high concentration of drug to be 
delivered to a local skin site, based on the principle that 
an electrical potential difference will actively cause ions 
in solution to migrate according to their electrical charge 
 [13] . Thus iontophoresis leads to reproducible enhance-
ment of transdermal permeability at a level sufficient to 
increase the number of diagnostic and therapeutic op-
portunities via the skin  [14] .
 The performance and reproducibility of these meth-
ods has been reported in a number of studies  [10, 13–16] , 
but technological improvements (e.g. in the probe design 
and laser light emission) have been made in recent years. 
Early LDF studies highlighted that the method was reli-
able for the short-term investigation of drug effects on the 
microcirculation and for quantifying changes in the cu-
taneous microvascular perfusion  [15, 16] . This conclu-
sion was drawn, despite the reported differences between 
proximal and distal sites of recordings  [16] and intra- and 
interindividual differences reported to be 34  8 4 and 41 
 8 5% for acetylcholine (ACh), and 34  8 4 and 29  8 3% 
for sodium nitroprusside (SNP), respectively  [13] . How-
ever, the introduction of newer, more sophisticated probes 
(e.g. use of a single laser Doppler fibre surrounded by sev-
eral receiving fibres) has improved results, as the study of 
a larger volume is enabled  [12] . In addition, and although 
the reproducibility of LDF has been evaluated in other 
contexts (e.g. choroidal blood perfusion  [17] ), studies in 
the lower limbs have been limited  [18] , with no reproduc-
ibility studies, to our knowledge, been undertaken in the 
upright position.
 Studies using LDI have reported better levels of repro-
ducibility. For example Kubli et al.  [19] , in a study under-
taken in the forearm, reported that the mean coefficient 
of variation (CV) of responses was  ! 10% for ACh and be-
tween 10 and 20% for SNP. Morris and Shore  [20] report-
ed slightly higher values for ACh (e.g. 23.2  8 12.4%), a 
finding that could potentially be attributed to possible 
different protocol and study conditions (i.e. the study by 
Kubli et al.  [19]  included only male participants, with to-
tal current charges of 22 and 38 mC for ACh and SNP, 
respectively, while Morris and Shore  [20] used both male 
and female participants and applied 7 pulses of 0.1 mA 
for 20 s followed by one pulse of 0.2 mA for 20 s).
 Although the reported reproducibility of LDF and LDI 
has been variable, it is clear that differences in study pop-
ulations, laser Doppler and iontophoresis equipment (i.e. 
using equipment with different penetration depth), the 
sites studied (i.e. upper or lower side of forearm  [21] ), and 
the conditions under which reproducibility was tested 
(i.e. different temperature levels) make meaningful com-
parisons between studies more difficult  [19] . Further-
more, and although the two techniques have been used 
interchangeably, the association between the measure-
ment output is unknown with the factors that affect them 
being poorly defined and understood.
 Thus the aim of this study was to determine the repro-
ducibility of LDF and LDI with iontophoresis in the low-
er limb in the supine and standing position. Additionally, 
we aimed to investigate factors that may influence each 
technique and make recommendations for future use of 
these techniques.
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 Methods 
 Patients with uncomplicated isolated superficial venous in-
competence (ISVI), i.e. long or short saphenous vein reflux (CEAP 
classification: C2–C3) confirmed by duplex scanning (conducted 
by a trained and accredited NHS clinical physiologist  [22] ), who 
were awaiting surgery were recruited from referrals to the Derby 
Royal Infirmary Vascular Clinic. Patients with present or past 
venous ulceration, arterial disease or major skin changes in the 
gaiter area were excluded. Healthy controls were recruited from 
the research database in the Division of Vascular Medicine, and 
the absence of ISVI confirmed by duplex scanning, conducted by 
a trained and accredited NHS Clinical Physiologist in the Derby 
Royal Infirmary Vascular Clinic. This research was carried out in 
accordance with the Declaration of Helsinki of the World Medical 
Association and all participants gave written informed consent. 
The protocol was approved by the Southern Derbyshire Local Re-
search Ethics Committee. Sample size calculations were based on 
our previous work on similar study groups  [23] .
 Following baseline screening, including measurement of 
height (metres), weight (kilograms), high-density lipoprotein, to-
tal cholesterol and blood pressure (mm Hg), participants attended 
the Clinical Research Unit on two separate study mornings, 2 
weeks ( 8 2 days) apart. Microvascular perfusion and vasodilator 
responses in the gaiter area were measured in a temperature-con-
trolled room according to the same, standard protocol on both 
study days. Measurements were undertaken in the morning hours 
(8.30–10.30), while participants were asked to refrain from smok-
ing and any food, tea and coffee intake prior to the experiment.
 Study Periods 
 Laser Doppler Fluximetry 
 Following 30 min rest with the leg supported at a 30° angle 
above the heart level, the gaiter area was cleaned with alcohol and 
dried. Two Perspex iontophoresis chambers were positioned over 
healthy skin (avoiding any area of lipodermatosclerosis or super-
ficial veins), approximately 2–5 cm apart on the surface of the leg, 
4–8 cm proximal to the medial malleolus. Then, 1% ACh (Sigma 
Chemicals, UK) and 1% SNP (Nipride, Roche Pharmaceuticals 
Ltd.) diluted in deionised HPLC-grade water were injected into 
the anodal and cathodal iontophoresis chambers, respectively, 
with the laser Doppler probe being positioned through the centre 
of each chamber. The choice of drug concentration and electric 
current was made, in order to minimise non-specific vasodilator 
effects  [24] .
 LDF measurements were made using the DRT4 (Moor Instru-
ments, Axminster, UK), including the skin temperature, perfu-
sion and microvascular dose-response curves for each iontopho-
retic challenge obtained. After achieving a stable recording of 
baseline perfusion, LDF responses to ACh and SNP were mea-
sured using an incremental-dose iontophoresis protocol  [1] . 
Thereafter, following a 10-min recovery period and the stabilisa-
tion of baseline perfusion recordings in the standing position, re-
peat measurements of vasodilator responses were performed, 
with the subject upright at exactly the same site to the one used in 
the supine position. The protocol was repeated on visit 2.
 Laser Doppler Imaging 
 LDI measurements using an LDI system (Perimed, Stock-
holm, Sweden) and following the same procedure and protocol as 
the one described above were undertaken on the same days as the 
LDF measurements, 2 h after completion of the latter and follow-
ing a recovery and stabilising period.
 The laser Doppler imager was adjusted to scan the area cov-
ered by the two iontophoresis chambers used to deliver the two 
agents, having a consistent distance from the subject’s leg (21 cm).
 A battery-powered constant current controller (Perimed) was 
used to provide a direct current for the drug iontophoresis. Both 
the duration and strength of the constant current of each dose 
were defined manually, according to the standard protocol de-
scribed above. Perfusion responses and the obtained images were 
stored after the end of each experiment on the computer con-
nected to the laser Doppler imager.
 Data Analysis 
 Microvascular perfusion measured by LDF combined with 
iontophoresis was determined using three parameters: mean and 
maximum perfusion (measured in perfusion units), and the area 
under the curve (AUC, unitless,  fig. 1 ). For LDI, the three param-
eters measured were minimum perfusion (volts), mean perfusion 
(volts) and maximum perfusion (volts). All quantities were mea-
sured at baseline and after each iontophoretic charge (250, 500, 
1,000 and 2,000   Cb). Baseline to 2,000   Cb was defined as the 
difference in perfusion between these two periods.
 Reproducibility was determined by comparison of the results 
from visit 1 and 2, for all the applied charges, both agents (ACh 
and SNP) and both positions (supine and standing), for each 
method separately.
 Statistical Analysis 
 Data obtained using commercial software systems (Moorsoft 
V1, Moor Instruments, UK for LDF and Perisoft, Perimed, Swe-
den for LDI) was transferred to a database (Excel 2000) and ana-
lysed using statistical software (SPSS version 14, SPSS, USA). Out-
come measures were first tested for normal distribution using the 
Kolmogorov-Smirnov goodness of fit test and normalised using 
logarithmic transformation if necessary before further analysis.
 In order to determine the reproducibility of the techniques in 
the supine and standing positions concordance correlation coef-
ficient  [25] and the mean within-subject CV were calculated. CV 
was calculated by dividing the within-subject standard deviation 
(SD) by the mean and expressing it as a percentage. The within-
subject SD was calculated as the square root of the residual mean 
square using two-way analysis of variance. In addition Bland-Alt-
man plots were used to assess reproducibility. Ninety-five percent 
of the differences between the two measurements ought to lie 
within 1.96 SD of the differences if good repeatability is present 
 [26] . Looking at the spread of points ensures that there is no rela-
tion between the magnitude of the response and the difference 
between the two measurements.
 Wilcoxon signed-rank test (for paired samples) and Bonfer-
roni corrections were used where appropriate. Data is presented 
as mean (SD). Correlation and equivalency tests (in the form of 
Pearson’s product-moment coefficient and Fisher’s exact tests) 
were used to determine the relationship between a number of 
methodological (position, vasodilator agent, dose), clinical and 
demographic factors (presence or absence of ISVI, gender, smok-
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ing habits, exercise and alcohol consumption). Based on the re-
sults of these tests an analysis of covariance (ANCOVA) model 
was developed to determine their influence on each measure and 
for each laser Doppler method separately. Similarly, bivariate 
analysis was undertaken using Pearson’s product-moment coef-
ficient to assess associations between LDF and LDI measures of 
endothelial function. Correlation coefficients were characterised 
according to Cohen  [27] , e.g. small if between 0.1 and 0.3, moder-
ate if being between 0.3 and 0.5 and large if being 0.5–1.0. As no 
well-established threshold exists, below which within-subject CV 
are considered as ‘good’ or ‘excellent’, we based our interpretation 
of the results on the work of Harris et al.  [28] which suggests that 
CVs are acceptable if  ! 35%.
 Results 
 LDF and LDI were undertaken in 25 ISVI and 26 con-
trol subjects. A detailed demographic summary is pre-
sented in  table 1 .
 Reproducibility 
 LDF. The findings from LDF for the three measures 
were compared for each iontophoretic dose, agent and 
position between the two visits. No statistically signifi-
cant differences were observed in measurements be-
tween the two visits (p = 0.77, Wilcoxon signed-rank 
test). Maximum perfusion was found to be the most re-
producible quantity at baseline to maximal charge ( ta-
ble 2 ,  fig. 2 ).
 LDI. Maximum and mean perfusion were found to 
have similar CV for LDI (ranging from 15.8 to 17.6% and 
from 15.2 to 18.7%, respectively), with minimum perfu-
sion having the lowest reproducibility ( table 2 ). No statis-
tically significant differences were observed in measure-
ments between the two visits, for both agents and posi-
tions studied (p = 0.80, Wilcoxon signed-rank test). A 
sample Bland-Altman plot is presented in  figure 3 .
 Perfusion and AUC Determinants 
 Separate ANCOVA models were developed to deter-
mine the factors that affect the different LDF and LDI 
measurement quantities. As our previous studies have in-
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Table 1.  Demographic characteristics of participants presented 
per group (data presented as mean 8 SD)
Control
(n = 26)
ISVI
(n = 25)
p value
Age, years 54812 53811 0.61
BMI 25.483.3 25.983.9 0.70
Height, m 1.7080.1 1.7280.2 0.71
Weight, kg 75811 78813 0.55
Systolic BP, mm Hg 125819 130824 0.32
Diastolic BP, mm Hg 7888 8189 0.34
Total cholesterol, mmol/l 5.281.4 5.681.3 0.30
High density lipoprotein,
mmol/l 1.5280.4 1.5980.5 0.29
BMI = Body mass index; BP = blood pressure.
 Klonizakis/Manning/Donnelly
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ferred  [1, 9, 23] , LDF measurement quantities are posi-
tively influenced by iontophoretic dose and the use of va-
sodilator agents and reduced in the standing position and 
when ISVI is present ( table  3 ). Similar results were ob-
tained during LDI measurements, with all three quanti-
ties being simultaneously influenced by the same factors. 
Conversely, gender was not found to be of significance for 
any measurement for both techniques, while smoking did 
not have a statistically significant effect on maximum per-
fusion, despite the fact that it affects mean perfusion and 
AUC in LDF and mean and minimum perfusion in LDI.
 Associations between Measurements and Techniques 
 The exploration of the associations between LDF and 
LDI measures was divided in two sections ( table  4 ). 
With respect to the intra-technique relationship, statis-
tically significant correlations were identified between 
LDI measures in ACh vasodilation measurements: e.g. 
LDI maximum perfusion with LDI mean perfusion (r = 
0.763, p  ! 0.001). Similarly for LDF, Maximum Perfu-
sion was strongly correlated with AUC (r = 0.78, p  ! 
0.001) and Mean Perfusion with AUC (r = 0.925, p  ! 
0.001).
 Intertechnique associations between different mea-
sures of microvascular vasodilator function were signifi-
cant, yet generally, moderate  [27] at best: i.e. LDI maxi-
mum perfusion with LDF maximum perfusion (r = 0.404, 
p = 0.016).
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 Fig. 2. Bland-Altman plot of maximum perfusion for ‘baseline to 
maximal charge’ (LDF). 
 Fig. 3. Bland-Altman plot of maximum perfusion for ‘baseline to 
maximal charge’ (LDI). 
Table 2. T he reproducibility of LDF and LDI measurements
Quantity ACh lying ACh standing SNP lying S NP standing
CV, % CCC CV, % CCC CV, % CCC CV,  % CCC
AUC (LDF) 28.4 0.68 29.6 0.64 30.7 0.64 31.8 0.58
Mean perfusion (LDF) 24.2 0.76 25.2 0.68 21.4 0.72 22.9 0.70
Maximum perfusion (LDF) 21.1 0.79 21.6 0.78 20.5 0.74 24.3 0.72
Minimum perfusion (LDI) 27.5 0.59 26.7 0.59 29.4 0.54 28.7 0.55
Mean perfusion (LDI) 18.7 0.71 17.7 0.78 15.2 0.84 16.4 0.80
Maximum perfusion (LDI) 17.6 0.81 15.8 0.83 15.9 0.82 17.4 0.80
CCC = Concordance correlation coefficient.
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Table 4.  Associations between LDF and LDI measures (ACh and SNP)
Mean
perfusion
(LDI)
Maximum
perfusion
(LDI)
Minimum
perfusion
(LDI)
Maximum
perfusion
(LDF)
AUC
(LDF)
Mean
perfusion
(LDF)
ACh
Mean perfusion
(LDI)
Pearson correlation – 0.763** 0.517** –0.056 –0.016 0.085
sig. (2-tailed) – 0.000 0.001 0.746 0.924 0.616
Maximum perfusion
(LDI)
Pearson correlation 0.763** – 0.394* 0.404* 0.414* 0.345*
sig. (2-tailed) 0.000 – 0.048 0.016 0.013 0.042
Minimum perfusion
(LDI)
Pearson correlation 0.517** 0.394* – 0.045 0.223 0.449**
sig. (2-tailed) 0.001 0.048 – 0.793 0.197 0.007
Maximum perfusion
(LDF)
Pearson correlation –0.056 0.404* 0.045 – 0.781** –0.265
sig. (2-tailed) 0.746 0.016 0.793 – 0.000 0.124
AUC
(LDF)
Pearson correlation 0.328 0.414* 0.223 0.781** – 0.925**
sig. (2-tailed) 0.054 0.013 0.197 0.000 – 0.000
Mean perfusion
(LDF)
Pearson correlation 0.471** 0.345* 0.449** –0.265 0.925** –
sig. (2-tailed) 0.004 0.042 0.007 0.124 0.000 –
SNP
Mean perfusion
(LDI)
Pearson correlation – 0.654** 0.200 0.109 0.147 –0.169
sig. (2-tailed) – 0.000 0.248 0.547 0.413 0.338
Maximum perfusion
(LDI)
Pearson correlation 0.654** – 0.133 –0.169 0.109 0.147
sig. (2-tailed) 0.000 – 0.432 0.338 0.547 0.413
Minimum perfusion
(LDI)
Pearson correlation 0.200 0.133 – 0.192 0.188 –0.006
sig. (2-tailed) 0.248 0.432 – 0.270 0.280 0.971
Maximum perfusion
(LDF)
Pearson correlation 0.109 –0.169 0.192 – 0.924** 0.235
sig. (2-tailed) 0.547 0.338 0.270 – 0.000 0.140
AUC
(LDF)
Pearson correlation 0.147 0.109 0.188 0.924** – 0.297
sig. (2-tailed) 0.413 0.547 0.280 0.000 – 0.098
Mean perfusion
(LDF)
Pearson correlation –0.169 0.147 –0.006 0.235 0.297 –
sig. (2-tailed) 0.338 0.413 0.971 0.140 0.098 –
** Correlation is significant at the 0.01 level (2-tailed). 
* Correlation is significant at the 0.05 level (2-tailed).
Table 3.  Relationship between LDF and LDI measures and determinants
Quantity LDF L DI
maximum mean AUC maxi mum mean minimum
Determinant
Iontophoretic dose 0.0001 0.0001 0.0001 0.0001 0.0001 0.001
Position 0.0001 0.0001 0.0001 0.0001 0.0001 0.0001
Vasodilatory agents 0.045 0.001 0.043 0.03 0.04 0.045
Presence of ISVI 0.016 0.039 0.022 0.02 0.03 0.02
Gender NS NS NS NS NS NS
Alcohol NS NS NS NS NS NS
Training NS NS NS NS NS NS
Smoking NS 0.012 0.037 NS 0.015 0.041
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 Discussion 
 Assessment of microvascular function is clinically im-
portant across a range of conditions including venous 
disease. Recent refinements in LDF equipment including 
the calculation algorithms  [29] have led to researchers 
 [16, 18, 30] supporting the use of LDF as an effective and 
useful tool for evaluating the cutaneous microcircula-
tion, provided that standardised procedures are followed 
 [12, 29] . Given that an assessment tool should be repro-
ducible, but the microvascular beds differ within the hu-
man circulation, this study provides important new in-
formation with respect to the reproducibility of LDF and 
LDI in the lower limb  [19] .
 Analysis of the three commonly used LDF parameters 
measuring microvascular perfusion and reactivity 
showed that maximum perfusion had the highest repro-
ducibility, with AUC having the lowest. With respect to 
LDI, maximum perfusion and mean perfusion were the 
most reproducible measures, whilst the minimum perfu-
sion was found to be the least reproducible.
 Direct comparison between LDI reproducibility stud-
ies can be very difficult  [10] but our findings are in gen-
eral agreement with previous reproducibility studies un-
dertaken in the upper limbs in normal subjects  [10, 19] 
and in patient populations  [21] . This suggests that the 
combined use of LDI and iontophoresis is reproducible, 
provided the recording sites are standardised and adher-
ence to a protocol is maintained.
 This is the first study to examine the reproducibility 
of both techniques and their standard measurement 
quantities in the upright position. Our findings suggest 
that using our standardised protocol the reproducibility 
in the standing position is similar to that obtained in the 
supine position ( table 2 ); we hope this study will pave the 
way for more studies in the upright position.
 In general, assessment by LDI was more reproducible 
than LDF. It is possible that the higher CV observed in 
LDF is affected by the dermal perfusion variations that 
occur within   1 mm2 of skin, which is the area that the 
LDF probe operates on  [11] , or the choice of measurement 
site (gaiter area), as this is one of the factors affecting LDF 
measurements  [12] . This could also reflect the fact that 
LDI involves simultaneous perfusion measurements in a 
very large number of points. The latter suggests that a di-
rect comparison between the two techniques based on 
absolute numbers should be avoided. We would recom-
mend that LDF should be used for studies requiring con-
tinuous measurements with LDI being utilised as a means 
of studying larger surface areas. The lack of strong asso-
ciation between the two techniques further supports this 
recommendation and suggests that the techniques can-
not be used interchangeably, an argument supported in 
the literature  [31] .
 The final part of this study explored the effects of a 
range of clinical parameters on the LDF and LDI mea-
surements. Iontophoretic dose, bodily position, vasodila-
tor agents, the presence of ISVI and smoking were more 
likely to influence both LDF and LDI measurements. 
Further work is needed to clarify the importance of this 
finding, however, it can be postulated that the combina-
tion of smoking and ISVI can be a very serious inhibitor 
of microvascular perfusion and reactivity.
 This study is the first to our knowledge to directly 
compare LDF and LDI combined with iontophoresis in 
both supine and standing positions in the lower limb and 
assess the reproducibility of standard measures, assessing 
their inter- and intratechnique associations and explor-
ing factors that affect them. We have shown that both 
LDF and LDI, in both positions, have a reproducibility 
similar to if not better than other biological measure-
ments  [32, 33] and, therefore, can be used in the study of 
the pathophysiology in a number of conditions affecting 
microcirculation (e.g. ISVI, diabetes) without any debate 
about their applicability. As we have successfully present-
ed on this occasion by studying the effect of a number of 
methodological, clinical and demographic factors, perfu-
sion measurements are affected by a combination of con-
ditions and parameters (e.g. ISVI, smoking and pro-
longed standing), an observation that can be helpful in 
the provision of clinical recommendations. 
 References  1 Klonizakis M, Yeung JM, Lingam K, Nash 
JR, Manning G, Donnelly R: Contrasting ef-
fects of varicose vein surgery on endothelial-
dependent and -independent cutaneous va-
sodilation in the perimalleolar region. Eur J 
Vasc Endovasc Surg 2006; 31: 434–438. 
 2 Rossi M, Carpi A, Galetta F, Franzoni F, San-
toro G: Skin vasomotion investigation: a use-
ful tool for clinical evaluation of microvas-
cular endothelial function? Biomed Pharma-
cother 2008; 62: 541–545. 
 3 Khan F, Elhadd TA, Greene SA, Belch JJF: 
Impaired skin microvascular function in 
children, adolescents and young adults with 
type 1 diabetes. Diabetes Care 2000; 23: 215–
220. 
 4 Robertson L, Lee AJ, Gallagher K, Carmi-
chael SJ, Evans CJ, McKinstry BH, Fraser SC, 
Allan PL, Weller D, Ruckley CV, Fowkes FG: 
Risk factors for chronic ulceration in pa-
tients with varicose veins: a case control 
study. J Vasc Surg 2009; 49: 1490–1498. 
 Reproducibility and Clinical Application 
of Laser Doppler Techniques 
Skin Pharmacol Physiol 2011;24:136–143 143
 14 Guy RG: Iontophoresis-recent develop-
ments. Int J Pharm 1998; 50: 371–374. 
 15 Muller P, Keller R, Imhof P: Laser Doppler 
flowmetry, a reliable technique for measur-
ing pharmacologically induced changes in 
cutaneous blood flow? Methods Find Exp 
Clin Pharmacol 1987; 9: 409–420. 
 16 De Boer EM, Bezemer PD, Bruynzeel DP: A 
standard method for repeated recording of 
skin blood flow using Laser Doppler flowm-
etry. Derm Beruf Umwelt 1989; 37: 58–62. 
 17 Gugleta K, Orgül S, Flammer I, Gherghel D, 
Flammer J: Reliability of confocal choroidal 
laser Doppler flowmetry. Invest Ophthalmol 
Vis Sci 2002; 43: 723–728. 
 18 Kvernebo K, Slagsvold CE, Stranden E, Kro-
ese A: Laser Doppler flowmetry in evalua-
tion of lower limb resting skin circulation: a 
study in healthy controls and atherosclerotic 
patients. Scand J Clin Lab Invest 1988; 48: 
 621–626. 
 19 Kubli S, Waeber B, Dalle-Ave A, Feihl F: Re-
producibility of laser Doppler imaging of 
skin blood flow as a tool to assess endothe-
lial function. J Cardiovasc Pharmacol 2000; 
 36: 640–648. 
 20 Morris SJ, Shore AC: Skin blood flow re-
sponses to the iontophoresis of acetylcholine 
and sodium nitroprusside in man: possible 
mechanisms. J Physiol 1996; 496: 531–542. 
 21 Brocx KA, Drummond PD: Reproducibility 
of cutaneous microvascular function assess-
ment using laser Doppler flowmetry and 
acetylcholine iontophoresis.  Skin Pharmacol 
Physiol 2009; 22: 313–321. 
 22 Talbot SR: B-mode evaluation of peripheral 
arteries and veins; in Zwiebel WJ: Introduc-
tion to Vascular Ultrasonography. New 
York, Grune & Stratton, 1986, p 351. 
 23 Klonizakis M, Yeung JM, Lingam K, Nash 
JR, Manning G, Donnelly R: Effects of pos-
ture and venous insufficiency on endotheli-
al-dependent and -independent cutaneous 
vasodilation in the perimalleolar region. Eur 
J Vasc Endovasc Surg 2003; 26: 100–104. 
 24 Droog EJ, Sjöberg F: Nonspecific vasodilata-
tion during transdermal iontophoresis: the 
effect of voltage over the skin. Microvasc Res 
2003; 65: 172–178. 
 25 Li KIL: A concordance correlation coeffi-
cient to evaluate reproducibility. Biometrics 
1989; 45: 255–268. 
 26 Bland JM, Altman DG: Statistical methods 
for assessing agreement between two meth-
ods of clinical measurement. Lancet 1986;
i:307–310. 
 27 Cohen J: Statistical Power Analysis for the 
Behavioral Sciences, ed 2. Hillsdale, Erl-
baum, 1988. 
 28 Harris RA, Padilla J, Hanlon KP, Rink LD, 
Wallace JP: Reproducibility of the Flow-me-
diated dilation response to acute exercise in 
overweight men. Ultrasound Med Biol 2007; 
 33: 1579–1585. 
 29 Schabauer AM, Rooke TW: Cutaneous laser 
Doppler flowmetry: applications and find-
ings. Mayo Clin Proc 1994; 69: 564–574. 
 30 Andreassen AK, Gullestad L, Holm T, Si-
monsen S, Kvernebo K: Endothelium-de-
pendent vasodilatation of the skin microcir-
culation in heart transplant recipients. Clin 
Transpl 1998; 12: 324–332. 
 31 Dhindsa M, Sommerlad SM, DeVan AE, 
Barnes JN, Sugawara J, Ley O, Tanaka H: In-
terrelationships among noninvasive mea-
sures of postischemic macro- and microvas-
cular reactivity. J Appl Physiol 2008; 105: 
 427–432. 
 32 Stergiou GS, Kollias A, Rarra VC, Roussias 
LG: Ambulatory arterial stiffness index: re-
producibility of different definitions. Am J 
Hypertens 2010; 23: 129–134. 
 33 de Simone G, Roman MJ, Koren MJ, Mensah 
GA, Ganau A, Devereux RB: Stroke volume/
pulse pressure ratio and cardiovascular risk 
in arterial hypertension. Hypertension 1999; 
 33: 800–805. 
 5 Wigley FM, Wise RA, Mikdashi J, Schaefer 
S, Spence RJ: The post-occlusive hyperemic 
response in patients with systemic sclerosis. 
Arthritis Rheum 1990; 33: 1620–1625. 
 6 Place MJ, Witt P, Hendricks D: Cutaneous 
blood-flow patterns in free flaps determined 
by laser Doppler flowmetry. J Reconstr Mi-
crosurg 1996; 12: 355–358. 
 7 Binggeli C, Spieker LE, Corti R, Sudano I, 
Stojanovic V, Hayoz D, Lüscher TF, Noll G: 
Statins enhance postischemic hyperemia in 
the skin circulation of hypercholesterolemic 
patients: a monitoring test of endothelial 
dysfunction for clinical practice? J Am Coll 
Cardiol 2003; 42: 71–77. 
 8 Bonetti PO, Lerman LO, Lerman A: Endo-
thelial dysfunction: a marker of atheroscle-
rotic risk. Arterioscler Thromb Vasc Biol 
2003; 23: 168–175. 
 9 Klonizakis M, Tew G, Michaels J, Saxton J: 
Impaired microvascular endothelial func-
tion is restored by acute lower-limb exercise 
in post-surgical varicose vein patients. Mi-
crovasc Res 2009; 77: 158–162. 
 10 Svedman C, Cherry GW, Strigini E, Ryan TJ: 
Laser Doppler imaging of skin microcircula-
tion. Acta Derm Venereol (Stockh) 1998; 78: 
 114–118. 
 11 Braverman IM, Keh A, Goldminz D: Corre-
lation of laser Doppler wave patterns with 
underlying microvascular anatomy. J Invest 
Dermatol 1990; 95: 283–286. 
 12 Cracowski JL, Minson CT, Salvat-Melis M, 
Halliwill JR: Methodological issues in the as-
sessment of skin microvascular endothelial 
function in humans. Trends Pharmacol Sci 
2006; 27: 503–508. 
 13 Noon JP, Walker BR, Hand MF, Webb DJ: 
Studies with iontophoretic administration of 
drugs to human dermal vessels in vivo: cho-
linergic vasodilatation is mediated by dilator 
prostanoids rather than nitric oxide. Br J 
Clin Pharmacol 1998; 45: 545–550. 
